These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22162109)

  • 41. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
    Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
    J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis, and activity of 2,6-diphenoxypyridine-derived factor Xa inhibitors.
    Phillips G; Davey DD; Eagen KA; Koovakkat SK; Liang A; Ng HP; Pinkerton M; Trinh L; Whitlow M; Beatty AM; Morrissey MM
    J Med Chem; 1999 May; 42(10):1749-56. PubMed ID: 10346927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 1.
    Quan ML; Liauw AY; Ellis CD; Pruitt JR; Carini DJ; Bostrom LL; Huang PP; Harrison K; Knabb RM; Thoolen MJ; Wong PC; Wexler RR
    J Med Chem; 1999 Jul; 42(15):2752-9. PubMed ID: 10425086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Substituted thiophene-anthranilamides as potent inhibitors of human factor Xa.
    Kochanny MJ; Adler M; Ewing J; Griedel BD; Ho E; Karanjawala R; Lee W; Lentz D; Liang AM; Morrissey MM; Phillips GB; Post J; Sacchi KL; Sakata ST; Subramanyam B; Vergona R; Walters J; White KA; Whitlow M; Ye B; Zhao Z; Shaw KJ
    Bioorg Med Chem; 2007 Mar; 15(5):2127-46. PubMed ID: 17227710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor.
    Roehrig S; Straub A; Pohlmann J; Lampe T; Pernerstorfer J; Schlemmer KH; Reinemer P; Perzborn E
    J Med Chem; 2005 Sep; 48(19):5900-8. PubMed ID: 16161994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The mechanism of action of rivaroxaban--an oral, direct Factor Xa inhibitor--compared with other anticoagulants.
    Samama MM
    Thromb Res; 2011 Jun; 127(6):497-504. PubMed ID: 20888031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Caspase-3 binds diverse P4 residues in peptides as revealed by crystallography and structural modeling.
    Fang B; Fu G; Agniswamy J; Harrison RW; Weber IT
    Apoptosis; 2009 May; 14(5):741-52. PubMed ID: 19283487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies of benzothiophene template as potent factor IXa (FIXa) inhibitors in thrombosis.
    Wang S; Beck R; Blench T; Burd A; Buxton S; Malic M; Ayele T; Shaikh S; Chahwala S; Chander C; Holland R; Merette S; Zhao L; Blackney M; Watts A
    J Med Chem; 2010 Feb; 53(4):1465-72. PubMed ID: 20121198
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crystal structures of two potent nonamidine inhibitors bound to factor Xa.
    Adler M; Kochanny MJ; Ye B; Rumennik G; Light DR; Biancalana S; Whitlow M
    Biochemistry; 2002 Dec; 41(52):15514-23. PubMed ID: 12501180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parallel synthesis and structure-activity relationships of a series of highly potent, selective, and neutral factor Xa inhibitors.
    Bauer SM; Goldman EA; Huang W; Su T; Wang L; Woolfrey J; Wu Y; Zuckett JF; Arfsten A; Huang B; Kothule J; Lin J; May B; Sinha U; Wong PW; Hutchaleelaha A; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2004 Aug; 14(15):4045-50. PubMed ID: 15225723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. E-novo: an automated workflow for efficient structure-based lead optimization.
    Pearce BC; Langley DR; Kang J; Huang H; Kulkarni A
    J Chem Inf Model; 2009 Jul; 49(7):1797-809. PubMed ID: 19552372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding.
    Laxmikanthan G; Blaber SI; Bernett MJ; Scarisbrick IA; Juliano MA; Blaber M
    Proteins; 2005 Mar; 58(4):802-14. PubMed ID: 15651049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of neutral P1 substituents.
    Nazaré M; Essrich M; Will DW; Matter H; Ritter K; Urmann M; Bauer A; Schreuder H; Dudda A; Czech J; Lorenz M; Laux V; Wehner V
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4191-5. PubMed ID: 15261268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, structure-activity relationships, X-ray crystal structure, and energetic contributions of a critical P1 pharmacophore: 3-chloroindole-7-yl-based factor Xa inhibitors.
    Shi Y; Sitkoff D; Zhang J; Klei HE; Kish K; Liu EC; Hartl KS; Seiler SM; Chang M; Huang C; Youssef S; Steinbacher TE; Schumacher WA; Grazier N; Pudzianowski A; Apedo A; Discenza L; Yanchunas J; Stein PD; Atwal KS
    J Med Chem; 2008 Dec; 51(23):7541-51. PubMed ID: 18998662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel factor Xa inhibitors based on a benzoic acid scaffold and incorporating a neutral P1 ligand.
    Nazaré M; Matter H; Klingler O; Al-Obeidi F; Schreuder H; Zoller G; Czech J; Lorenz M; Dudda A; Peyman A; Nestler HP; Urmann M; Bauer A; Laux V; Wehner V; Will DW
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2801-5. PubMed ID: 15125936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 7-fluoroindazoles as potent and selective inhibitors of factor Xa.
    Lee YK; Parks DJ; Lu T; Thieu TV; Markotan T; Pan W; McComsey DF; Milkiewicz KL; Crysler CS; Ninan N; Abad MC; Giardino EC; Maryanoff BE; Damiano BP; Player MR
    J Med Chem; 2008 Jan; 51(2):282-97. PubMed ID: 18159923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ligand binding stepwise disrupts water network in thrombin: enthalpic and entropic changes reveal classical hydrophobic effect.
    Biela A; Sielaff F; Terwesten F; Heine A; Steinmetzer T; Klebe G
    J Med Chem; 2012 Jul; 55(13):6094-110. PubMed ID: 22612268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fragment deconstruction of small, potent factor Xa inhibitors: exploring the superadditivity energetics of fragment linking in protein-ligand complexes.
    Nazaré M; Matter H; Will DW; Wagner M; Urmann M; Czech J; Schreuder H; Bauer A; Ritter K; Wehner V
    Angew Chem Int Ed Engl; 2012 Jan; 51(4):905-11. PubMed ID: 22190348
    [No Abstract]   [Full Text] [Related]  

  • 59. Reconstructing the binding site of factor Xa in trypsin reveals ligand-induced structural plasticity.
    Reyda S; Sohn C; Klebe G; Rall K; Ullmann D; Jakubke HD; Stubbs MT
    J Mol Biol; 2003 Jan; 325(5):963-77. PubMed ID: 12527302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cis-amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinase.
    Staben ST; Blaquiere N; Tsui V; Kolesnikov A; Do S; Bradley EK; Dotson J; Goldsmith R; Heffron TP; Lesnick J; Lewis C; Murray J; Nonomiya J; Olivero AG; Pang J; Rouge L; Salphati L; Wei B; Wiesmann C; Wu P
    Bioorg Med Chem Lett; 2013 Feb; 23(3):897-901. PubMed ID: 23265894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.